Ben Wright

BEN WRIGHT acts for private equity sponsors, their portfolio companies, and corporate borrowers on financings for complex cross-border transactions.

Ben draws on a comprehensive understanding of market terms, deep technical knowledge, and extensive transactional experience to help clients navigate leveraged and investment-grade financings, with a focus on private equity transactions, including:

• Private and public acquisition financings;
• Syndicated term loan financings;
• Private credit financings;
• Bridge-to-bond and super senior revolving credit facility financings in high yield bond transactions;
• Holdco financings; and
• Post-IPO and public company financings.

Ben has been recognized by Chambers UK 2026 as an “Up and Coming” lawyer for Leveraged Finance: Big Ticket, where sources describe him as “a great outside the box thinker who is super smart. ” He has also been recommended by Legal 500 UK 2026 for Acquisition Finance.

Recent examples of Ben’s work include advising:

• Adevinta, a leading European online classifieds group backed by a consortium of shareholders including Blackstone and Permira, on financing arrangements to refinance its existing debt facilities and facilitate a distribution to shareholders.
• Astorg Partners, including in relation to its investments in:
  
  • CordenPharma, a contract development and manufacturing company (CDMO).
  • IPCOM, a pan-European distributor of technical and building insulation products.
  • LGC (as part of a consortium with Cinven), a global leader in the life sciences tools sector.
• CD&R (as part of a consortium with Permira) in relation to its investment in Exclusive Networks, a global provider of cybersecurity and cloud solutions, including in connection with Exclusive Networks’ €1.077 billion and US$267 million syndicated term and revolving facilities.
• CVC, including in relation to its investments in:
  
  • Breitling, an independent Swiss watchmaker.
  • Business Integration Partners, a European consulting company.
• Nordic Capital, including in relation to its investments in:
  • Alloheim, a German care home operator.
  • Intrum, a credit management services provider.
  • Nordax Group, a niche bank in Northern Europe, including on Nordax Group’s acquisition of Bank Norwegian.
  • Sunrise Medical, a leader in premium mobility products.
• Onex, including in relation to its investments in:
  
  • Acacium Group, a specialized staffing, workforce management solutions, and health and social services business.
  • SIG Combibloc Group, a provider of aseptic carton packaging solutions for beverages and liquid food.
  • TES Global, an international provider of comprehensive software solutions for the education sector.
• Partners Group, including in relation to its investments in:
  • MPM Products, a global pet food business focused on premium cat food.
  • Pharmathen, a leading European pharmaceutical company.
  • Rosen Group, a global provider of mission-critical inspection services for energy infrastructure assets.
• PAI Partners, including on the public-to-private acquisition of Koninklijke Wessanen (now Ecotone), a healthy and sustainable food company.
• Permira, including in relation to its investments in:
  
  • Adevinta (as part of a consortium with Blackstone and others), the world’s largest online classified advertising business, including in connection with financing arrangements to refinance its existing debt facilities and facilitate a distribution to shareholders.
  • Gruppo Florence, a leading Italian manufacturer of textiles for the international luxury sector.
  • BestSecret, an omnichannel retail premium fashion community for private members in the DACH region.
  • CABB International, a German chemicals business.
  • Exclusive Networks, a global provider of cybersecurity and cloud solutions.
  • GFKL Financial Services, a receivables management services provider in Germany, and Lowell Group, a credit management services provider in the UK.
  • Golden Goose, including in connection with the issuance of €480 million in euro senior secured floating rate notes due 2031 and related €100 million revolving credit facility.
  • JTC plc, a FTSE 250-listed provider of fund administration, corporate and trust services, including in connection with the €1.5 billion private credit facilities to finance Permira’s £2.3 billion recommended cash offer for JTC plc.
  • Kedrion and Bio Products Laboratory, two providers of medicinal products derived from human blood plasma.
  • Neuraxpharm, a specialty pharmaceutical company focused on treating central nervous system disorders, including in connection with its successful €925 million term loan B refinancing.
  • Quotient Sciences, a drug development and manufacturing accelerator.
  • Soho House & Co Inc. on its financing arrangements, including in relation to its definitive agreements pursuant to which an investor group led by MCR, and its chairman and CEO Tyler Morse will acquire the outstanding shares of Soho House.

Some of the above matters were handled prior to joining Sidley.